Abstract | BACKGROUND: Transsphenoidal surgery is safe and effective in patients with secreting pituitary adenomas; however, variable outcomes have been reported according to the different criteria used to define the biochemical remission of hormone hypersecretion. We report the long-term endocrinologic follow-up results of a large cohort of patients who underwent TSS for secreting pituitary adenomas according to the most recent stringent criteria of cure. METHODS: Two hundred ten consecutive patients were operated on by TSS between 1995 and 2004 for a secreting pituitary adenoma (65 PRL-, 109 GH-, and 36 ACTH-secreting adenomas) and were considered for the study. RESULTS: The overall remission rate was 65% for the whole series, being 64%, 61%, and 75% for PRL-, GH-, and ACTH-secreting adenomas, respectively. Eighty-six percent of microadenomas and 53% of macroadenomas were cured by surgery. Remission rates were significantly higher in GH- and ACTH-secreting pituitary macroadenomas than in macroprolactinomas. At a median follow-up of 56 months, tumor recurrence was 0%, 11%, and 14% for GH-, ACTH-, and PRL-secreting tumors. Tumor size, cavernous sinus invasion, and high hormone levels were negatively correlated to the outcome. CONCLUSION: Transsphenoidal surgery remains an effective treatment for secreting pituitary tumors according to the most recent criteria of cure. Patients with PRL- or ACTH-secreting adenomas may recur after apparently successful surgery, thereby justifying long-term careful endocrinologic follow-up.
|
Authors | Antonio Santoro, Giuseppe Minniti, Andrea Ruggeri, Vincenzo Esposito, Marie-Lise Jaffrain-Rea, Roberto Delfini |
Journal | Surgical neurology
(Surg Neurol)
Vol. 68
Issue 5
Pg. 513-8; discussion 518
(Nov 2007)
ISSN: 0090-3019 [Print] United States |
PMID | 17961741
(Publication Type: Journal Article)
|
Chemical References |
- Pituitary Hormones, Anterior
|
Topics |
- Adenoma
(blood, metabolism, surgery)
- Adolescent
- Adult
- Aged
- Female
- Follow-Up Studies
- Humans
- Hyperpituitarism
(blood, etiology, prevention & control)
- Male
- Middle Aged
- Pituitary Hormones, Anterior
(blood, metabolism)
- Pituitary Neoplasms
(blood, metabolism, surgery)
- Recurrence
- Remission Induction
- Retrospective Studies
- Time Factors
- Treatment Outcome
|